HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
2.680
-0.245 (-8.38%)
At close: Aug 14, 2026, 4:00 PM EDT
2.700
+0.020 (0.75%)
After-hours: Aug 14, 2026, 7:37 PM EDT
HCW Biologics Market Cap
HCW Biologics has a market cap or net worth of $3.2 million as of August 14, 2026. Its market cap has decreased by -60.71% in one year.
Market Cap
3.20M
Enterprise Value
8.55M
1-Year Change
-60.71%
Ranking
Category
Stock Price
$2.68
ChartMarket Cap Chart
Since the IPO on July 20, 2021, HCW Biologics's market cap has decreased from $285.20M to $3.20M, a decrease of -98.88%. That is a compound annual growth rate of -58.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 3.20M | 21.98% |
| Dec 31, 2025 | 2.62M | -86.80% |
| Dec 31, 2024 | 19.87M | -54.91% |
| Dec 29, 2023 | 44.07M | -35.84% |
| Dec 30, 2022 | 68.69M | -17.13% |
| Dec 31, 2021 | 82.89M | -70.94% |
| Jul 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 3.68M |
| Curis | 3.63M |
| TransCode Therapeutics | 3.51M |
| Galmed Pharmaceuticals | 3.45M |
| Moleculin Biotech | 3.38M |
| 60 Degrees Pharmaceuticals | 3.14M |
| Onconetix | 3.07M |
| Jupiter Neurosciences | 3.02M |